Jason Cathelyn, Vice President of Intellectual Property
Professional Overview
Jason Cathelyn is an accomplished intellectual property (IP) leader with extensive experience managing complex patent portfolios and driving strategic IP initiatives. As the Vice President of Intellectual Property at Disc Medicine, he leverages his deep industry knowledge and technical expertise to support the company's innovative drug development efforts.
Experience Summary
Current Role
As the Vice President of Intellectual Property at Disc Medicine, Jason is responsible for overseeing the company's global IP strategy, portfolio management, and patent prosecution efforts. He works closely with cross-functional teams to identify, protect, and maximize the value of Disc Medicine's innovative pipeline. Under his leadership, the IP team has successfully secured numerous patents, ensuring robust intellectual property protection for the company's groundbreaking therapies.
Career Progression
Prior to joining Disc Medicine, Jason served as the Vice President of Intellectual Property at Acceleron Pharma, where he progressively advanced through various roles, including Senior Director, Director, and Associate Director of Intellectual Property. In these positions, he played a pivotal role in building and managing Acceleron's extensive patent portfolio, which contributed to the company's strategic growth and successful acquisition by Merck.
Before transitioning to an in-house IP role, Jason was a Senior Patent Agent at the prestigious law firm Ropes & Gray LLP, where he provided IP counseling and prosecution services to a diverse client base in the life sciences industry.
Academic Background
Jason holds a Juris Doctor degree from Boston University School of Law and a Bachelor of Science degree in Biochemistry from the University of Massachusetts Amherst. He is a licensed patent agent with the United States Patent and Trademark Office, bringing a unique combination of legal expertise and scientific acumen to his work.
Areas of Expertise
- Intellectual property strategy and portfolio management
- Patent prosecution and litigation
- Biopharmaceutical drug development and commercialization
- Regulatory compliance and intellectual property law
- Cross-functional collaboration and team leadership
Professional Impact
Throughout his career, Jason has been instrumental in securing critical patent protection for numerous innovative therapies, contributing to the successful advancement and commercialization of life-changing treatments. His strategic guidance and technical expertise have played a pivotal role in supporting the growth and success of the organizations he has served.
Conclusion
With his extensive experience, deep industry knowledge, and proven track record of success, Jason Cathelyn is a valuable asset to Disc Medicine, where he continues to drive the company's IP strategy and support the development of transformative therapies that positively impact patient lives.
